Genetic, Health, Medical
Genetic, Health, MedicalbyDr Fouad Bitar

Avigena Awarded Patents for First Arab-Focused PRS for Heart Disease and Breast Cancer

Press Release 

June 25, 2025

Avigena Biosciences is proud to announce that its co-founders have been granted Patent No.
13249 and 13250 by Lebanon’s Intellectual Property Protection Office (IPPS) for the
development of proprietary Polygenic Risk Scores (PRS) for Coronary Artery Disease (CAD)
and Breast Cancer (BC)—the first PRS models tailored for Arab and Middle Eastern
populations.

This milestone marks a major scientific breakthrough, providing regionally optimized genomic
tools that improve disease risk prediction and support Avigena’s mission to deliver equitable,
preventive precision care across the Arab world and beyond.

Videos
VideosbyDr Fouad Bitar

Avigena OmniInsight Coronary Artery Disease (CAD) AR

Avigena OmniInsight Coronary Artery Disease

Avigena OmniInsight helps uncover genetic risk for Coronary Artery Disease, enabling earlier detection and more informed clinical decisions. Learn how precision genomics can support proactive cardiovascular care.

Continue Watching

Subscribe to get more video.

Videos
VideosbyDr Fouad Bitar

Dr. Hazem Assi Polygenic Risk Score

Polygenic Risk Score

Understanding your genetic risk just got more precise. A Polygenic Risk Score (PRS) is a one-time, saliva-based DNA test that analyzes thousands to millions of genetic variants (SNPs) to estimate an individual’s inherited risk of developing conditions such as heart disease, breast cancer, or prostate cancer—years before the disease begins.

Continue Watching

Subscribe to get more video.

Videos
VideosbyDr Fouad Bitar

Dr. Hazem Assi PRS

Polygenic Risk Score

Understanding your genetic risk just got more precise. A Polygenic Risk Score (PRS) is a one-time, saliva-based DNA test that analyzes thousands to millions of genetic variants (SNPs) to estimate an individual’s inherited risk of developing conditions such as heart disease, breast cancer, or prostate cancer—years before the disease begins.

Continue Watching

Subscribe to get more video.

Webinars
WebinarsbyDr Fouad Bitar

Webinar: Polygenic Risk Scores in the 2026 ACC/AHA Dyslipidemia Guidelines New Risk Enhancers for Cardiovascular Prevention

Start Date

June, 2026

location

Online

organiser

Avigena

Description

Presented by Akl Fahed, MD, MPH (Interventional Cardiologist & Physician-Scientist)

Massachusetts General Hospital & Harvard Medical School

Member, Broad Institute

 

Overview

Polygenic risk scores (PRS) are transforming cardiovascular prevention by enabling earlier identification of inherited risk for atherosclerotic cardiovascular disease. In this webinar, Dr. Fahed reviews the evidence supporting PRS and their recognition as risk-enhancing factors in the 2026 ACC/AHA Dyslipidemia Guidelines, highlighting their role in risk stratification and precision cardiovascular prevention.

 

Originally presented at the Lebanese Society of Cardiology Regional Conference (June 2026).

Watch The Full Webinar Here

Google Calendar

Easily add to your calendar

1 2 3 4
[email protected]